Search Results
Mar 10, 2026, 09:15 ET New AI Solution Helps Predict Which Lung Cancer Patients Will Benefit from Immunotherapy
response."AI is allowing us to uncover hidden biological signals from medical images that were previously invisible to the human eye," said Anant Madabhushi, PhD, Chief Scientific Officer at Picture Health. "By quantifying the architecture of tumor blood vessels from routine CT scans, QVT provides a new way to
More news about: Picture Health
Mar 10, 2026, 09:13 ET AOiA Positioned as Early Leader as CMS Elevates Digital Health Evaluation Nationwide
clear, credible, and structured way to prove the quality of their products to the markets and the populations they serve," said Benjamin Vandendriessche, PhD, president and chief scientific officer of DiMe. "The AOIA recognized this critical need early on and has been an instrumental partner in building this
More news about: American Osteopathic Association
Mar 10, 2026, 09:01 ET Visage Elevates AI Optimized Enterprise Imaging at HIMSS26
generation, and error checking."Our differentiated Visage 7 architecture is AI optimized and purpose built for the cloud," said Malte Westerhoff, PhD, Visage Co-Founder and Global Chief Technology Officer. "We take great pride in inventing new workflows that deliver rapid improvements for customers,
More news about: Visage Imaging, Inc.
Mar 10, 2026, 09:00 ET Kai Emerges from Stealth with $125M, Powering Machine-Speed Defense to Outpace AI-Enabled Adversaries
Code to Fortune 500 Adoption Kai is not another security tool wrapped around Large Language Models. It is an agentic AI platform built by PhD- and postdoctoral-level AI researchers, as well as category-defining operators at the forefront of the latest Generative AI wave. In just 10 months
More news about: Kai
Mar 10, 2026, 09:00 ET Kai Emerges from Stealth with $125M, Powering Machine-Speed Defense to Outpace AI-Enabled Adversaries
Code to Fortune 500 Adoption Kai is not another security tool wrapped around Large Language Models. It is an agentic AI platform built by PhD- and postdoctoral-level AI researchers, as well as category-defining operators at the forefront of the latest Generative AI wave. In just 10 months
More news about: Kai
Mar 10, 2026, 08:56 ET CounterX Therapeutics Executes Exclusive Licensing Agreement for Portfolio of Novel Monoclonal Antibody and Vaccine Candidates Targeting Fentanyl and Opioid Overdose
intervention and prevention, and to counteract other chemical threats of national interest.The licensed technology was developed by Marco Pravetoni, PhD., Founder and Chief Scientific Officer of CounterX Therapeutics in his role as a faculty at the University of Minnesota and the University of Washington.
More news about: CounterX Therapeutics
Mar 10, 2026, 08:32 ET The American Diabetes Association Announces the 2026 National Scientific and Health Care Achievement Award Winners
complications.Mary R. Loeken, PhD (Joslin Diabetes Center and Harvard Medical School): Norbert Freinkel AwardThis award honors outstanding scientific achievement in the understanding and treatment of diabetes and pregnancy.Korey K. Hood, PhD (Stanford University
More news about: American Diabetes Association
Mar 10, 2026, 08:30 ET MiDOG Animal Diagnostics Launches Comprehensive Whole Genome Sequencing Test Covering Bacteria, Fungi, Parasites, Antimicrobial Resistance, and Virulence Factors in a Single Assay
infections more effectively.""Whole genome sequencing provides the full picture with essential details clinicians need," said Shuiquan Tang, PhD, CSO at MiDOG Animal Diagnostics. "This is especially important for animal infections, which frequently involve polymicrobial communities, biofilm formation,
More news about: MiDOG Animal Diagnostics
Mar 10, 2026, 08:10 ET UL Research Institutes Announces Judy Jeevarajan, Ph.D., as Vice President & Distinguished Scientific Advisor
multimedia:https://www.prnewswire.com/news-releases/ul-research-institutes-announces-judy-jeevarajan-phd-as-vice-president--distinguished-scientific-advisor-302709442.htmlSOURCE
More news about: UL Research Institutes
Mar 10, 2026, 08:03 ET Genomenon and Amicus Therapeutics Partner to Advance Fabry Disease Awareness and Diagnosis
Genomenon expands access to high‑quality genetic insights that can accelerate diagnosis and support more informed clinical decisions," said Jeff Castelli, PhD, Chief Development Officer, Amicus Therapeutics, Inc. "By combining our Fabry expertise with Genomenon's genomic intelligence, we hope to help more patients
More news about: Genomenon
Mar 10, 2026, 08:00 ET NEW REPORT FROM HILL'S PET NUTRITION FINDS LARGE DOGS FACE DISPROPORTIONATE BARRIERS TO ADOPTION
understanding of their specific needs. As a leading veterinarian recommended pet food brand, knowledge is our first ingredient with nearly 200 veterinarians, PhD nutritionists and food scientists working to develop breakthrough innovations in pet health. Hill's Prescription Diet therapeutic nutrition plus our
More news about: Hill's Pet Nutrition
Mar 10, 2026, 08:00 ET Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health
glycemic improvement. "Our findings reinforce that engagement is not just a usage metric – it is a clinical signal," said Yifat Hershcovitz, PhD, VP Clinical & Scientific Affairs at Dario and senior author of the study. "We observed a substantial early reduction in blood glucose followed by
More news about: DarioHealth Corp.
Mar 10, 2026, 07:30 ET Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
composition of matter for dusquetide and related analogs. Dusquetide was developed pursuant to discoveries made by Professors B. Brett Finlay, PhD and Robert Hancock, PhD of the University of British Columbia, Canada. Dusquetide has been awarded
More news about: SOLIGENIX, INC.
Mar 10, 2026, 07:00 ET Artmarket.com publie le 32e Rapport Artprice du Marché de l'Art en 2025 en croissance +12 %, les USA renforcent leur 1ère place, l'audit AI de Gemini Deep Think sur le Marché de l'art 2026/2030 par Artprice
demandé à Google Gemini 3 Ultra Mode Deep Think actuellement considéré comme le meilleur moteur Mondial en IA/AI sur le raisonnement de niveau PhD. (grade de docteur (PhD) correspond à un niveau bac + 8), la multimodalité et ses fenêtre contextuelle : avec une capacité dépassant le million de tokens, il peut
More news about: Artmarket.com
Mar 10, 2026, 04:53 ET Huawei představuje vizi „Posun mobility a logistiky do inteligentního světa" pro dopravu, založenou na pěti nových řešeních
PhD. Reha Çetin, výkonný ředitel pro informační systémy a technologie Istanbul Grand Airport a generální ředitel IST Systems, zdůraznil, že jako nejrychleji
More news about: Huawei
Mar 09, 2026, 22:47 ET 華為發佈五大全新解決方案，邁向交通運輸行業全面智能化
來自全球交通運輸行業的客戶、夥伴分享了與華為的合作成果：伊斯坦布爾機場CIO PhD Reha Çetin指出，伊斯坦布爾機場作為歐洲增長最快的航空樞紐，依托華為領先的數字技術與ICT 能力，將持續推進機場5.0數字化轉型戰略的實施，提供未來機場的體驗。軌道交通的發展催生了通信技術的需求。通號國際副總經理任再銘分享了FRMCS技術在提升列車運行效率、鐵路運力、優化全生命週期成本等場景的應用，助力未來鐵路系統運行更高效、安全。人工智能將成為智能交通運輸系統的「神經中樞」。SICE交通主管Carlos
More news about: 華為
Mar 09, 2026, 18:55 ET Myosin Therapeutics Invited to Present at Two South Florida Life Sciences Conferences
Courtney Miller, PhD, Chief Executive Officer of Myosin Therapeutics, will present the company's platform and pipeline strategy, including the development of MT-125, a first-in-class
More news about: Myosin Therapeutics Inc.
Mar 09, 2026, 14:04 ET Glaucoma Research Foundation Announces Record $3.06 million in Annual Research Grants to Fund their 2026 Shaffer Grants and Catalyst for a Cure Research Collaborations
Chang, PhD, Shruthi Karnam, PhD, Kate Keller, PhD, Naoki Kiyota, MD, PhD, Gillian McLellan, PhD, Kiyoharu Miyagishima, PhD, Kerstin Nundel, PhD, Shruti Patil, PhD, Lev Prasov, MD, PhD, Maria Fernanda Suarez, PhD, Levi Todd, PhD, and Lauren
More news about: Glaucoma Research Foundation
Mar 09, 2026, 13:45 ET CENTURY LITHIUM FILES TECHNICAL REPORT ON THE FEASIBILITY STUDY FOR THE ANGEL ISLAND LITHIUM PROJECT, NEVADA
centurylithium.com.ON BEHALF OF CENTURY LITHIUM CORP.WILLIAM WILLOUGHBY, PhD., PE President & Chief Executive OfficerNEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY
More news about: Century Lithium Corp.
Mar 09, 2026, 13:38 ET NEW INDEPENDENT STUDY FROM DNA&STONE'S CSO FINDS PERSISTENT GENDER PAY GAP IN U.S. ADVERTISING INDUSTRY
DNA&STONE, the full-service agency that leads with Radical Empathy, in collaboration with Nancy L. Wayne, PhD, of UCLA and Ryan D. Krone, PhD, of Elite Research, LLC, has released a new independent research study titled
More news about: DNA&STONE
Mar 09, 2026, 13:38 ET US Air Force awarded 25 million dollar contract to ZAC, the pioneer of Cognitive Explainable-AI, which is the foundation for Autonomous Driving Level-5
development is headed by Dr. Saied Tadayon, a scientist, veteran software developer, and math prodigy, who ranked 1st as an undergrad at Cornell, with his PhD in Electrical Engineering from Cornell at age 23 (the youngest).ZAC world-renowned advisors include: Prof. David Lee (Nobel Laureate, Physics),
More news about: Z Advanced Computing, Inc.
Mar 09, 2026, 13:04 ET Huawei presenta su visión "Impulsando la movilidad y la logística hacia un mundo inteligente"
PhD. Reha Çetin, responsable de información del Aeropuerto Internacional de Estambul y consejero delegado de IST Systems, destacó que, como el centro de
More news about: Huawei
Mar 09, 2026, 11:24 ET Huawei Debuts "Driving Mobility and Logistics into the Intelligent World" Vision for Transportation, Powered by Five New Solutions
PhD. Reha Çetin, CIO of Istanbul Grand Airport and CEO of IST Systems, highlighted that as Europe's fastest-growing aviation hub, Istanbul Airport will continue
More news about: Huawei
Mar 09, 2026, 10:51 ET AI use in diagnostic care, rural care access, and surge in preventable diseases top annual report of patient safety concerns
seeing decades of hard-won progress in public health erode in the fight against diseases like measles and whooping cough," said Marcus Schabacker, MD, PhD, president and chief executive officer of ECRI. "Now more than ever healthcare leaders must be proactive and creative to tackle these challenges."ECRI's
More news about: ECRI
Mar 09, 2026, 08:30 ET Hakuhodo and Corundum Systems Biology to Co-Host Next Two Global Deep Tech VC Seminar Sessions
providing insights from both researchers and business leaders. Speakers: Eran Segal, PhD, Professor at the Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, and Ori Cohen, PhD, Co-Founder and CEO of Pheno.AI LtdLanguage: EnglishRegistration:
More news about: Corundum Systems Biology